Concepts (102)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Phosphatidylcholines | 3 | 2010 | 48 | 0.990 |
Why?
|
| Plasminogen | 2 | 2010 | 41 | 0.750 |
Why?
|
| Apoprotein(a) | 2 | 2010 | 3 | 0.710 |
Why?
|
| Apolipoproteins A | 2 | 2005 | 11 | 0.510 |
Why?
|
| 1-Alkyl-2-acetylglycerophosphocholine Esterase | 2 | 2010 | 35 | 0.480 |
Why?
|
| Lipoprotein(a) | 3 | 2009 | 28 | 0.420 |
Why?
|
| Lipoproteins, LDL | 2 | 2009 | 83 | 0.420 |
Why?
|
| Phospholipids | 2 | 2008 | 111 | 0.400 |
Why?
|
| Apolipoprotein A-II | 1 | 2008 | 3 | 0.340 |
Why?
|
| Lipoproteins, HDL | 1 | 2008 | 96 | 0.320 |
Why?
|
| Apolipoprotein A-I | 1 | 2008 | 71 | 0.320 |
Why?
|
| Fibronectins | 1 | 2005 | 93 | 0.260 |
Why?
|
| Lysine | 1 | 2003 | 147 | 0.220 |
Why?
|
| Oxidation-Reduction | 2 | 2010 | 373 | 0.170 |
Why?
|
| Protein Processing, Post-Translational | 3 | 2008 | 371 | 0.160 |
Why?
|
| Proteomics | 2 | 2008 | 211 | 0.140 |
Why?
|
| Atherosclerosis | 2 | 2008 | 245 | 0.130 |
Why?
|
| Carotid Stenosis | 2 | 2008 | 112 | 0.130 |
Why?
|
| Macrophages | 2 | 2009 | 557 | 0.120 |
Why?
|
| Protein Structure, Tertiary | 2 | 2005 | 736 | 0.110 |
Why?
|
| Kringles | 2 | 2009 | 6 | 0.110 |
Why?
|
| Macaca mulatta | 2 | 2005 | 459 | 0.100 |
Why?
|
| Amino Acid Sequence | 2 | 2005 | 2062 | 0.090 |
Why?
|
| Hep G2 Cells | 1 | 2010 | 48 | 0.090 |
Why?
|
| Phospholipases A2 | 1 | 2009 | 44 | 0.090 |
Why?
|
| Molecular Sequence Data | 2 | 2005 | 3030 | 0.090 |
Why?
|
| Mass Spectrometry | 1 | 2010 | 189 | 0.090 |
Why?
|
| Animals | 5 | 2010 | 26590 | 0.090 |
Why?
|
| Hepatocytes | 1 | 2009 | 127 | 0.080 |
Why?
|
| Glycosphingolipids | 1 | 2008 | 3 | 0.080 |
Why?
|
| Solutions | 1 | 2008 | 85 | 0.080 |
Why?
|
| Chromosomes, Human, Pair 6 | 1 | 2009 | 125 | 0.080 |
Why?
|
| Protein Isoforms | 1 | 2009 | 270 | 0.080 |
Why?
|
| Carotid Arteries | 1 | 2008 | 127 | 0.080 |
Why?
|
| Humans | 10 | 2010 | 86678 | 0.070 |
Why?
|
| Mice | 2 | 2010 | 11356 | 0.070 |
Why?
|
| Recombinant Proteins | 2 | 2009 | 1015 | 0.070 |
Why?
|
| Mice, Knockout | 1 | 2010 | 1924 | 0.070 |
Why?
|
| Pancreatic Elastase | 1 | 2005 | 15 | 0.070 |
Why?
|
| Freeze Drying | 1 | 2004 | 14 | 0.060 |
Why?
|
| Methods | 1 | 2004 | 152 | 0.060 |
Why?
|
| Drug Stability | 1 | 2004 | 48 | 0.060 |
Why?
|
| Indicators and Reagents | 1 | 2004 | 72 | 0.060 |
Why?
|
| Cryopreservation | 1 | 2004 | 69 | 0.060 |
Why?
|
| Vasculitis | 1 | 2003 | 39 | 0.060 |
Why?
|
| Luminescent Measurements | 1 | 2003 | 57 | 0.060 |
Why?
|
| Interleukin-8 | 1 | 2003 | 86 | 0.060 |
Why?
|
| Reference Standards | 1 | 2004 | 159 | 0.060 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 2003 | 268 | 0.060 |
Why?
|
| Phosphorus | 1 | 2003 | 118 | 0.060 |
Why?
|
| Culture Media, Conditioned | 1 | 2003 | 104 | 0.060 |
Why?
|
| Immunoblotting | 1 | 2003 | 268 | 0.060 |
Why?
|
| Cells, Cultured | 2 | 2009 | 2819 | 0.060 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2003 | 376 | 0.050 |
Why?
|
| Lipid Metabolism | 1 | 2003 | 197 | 0.050 |
Why?
|
| Temperature | 1 | 2003 | 396 | 0.050 |
Why?
|
| Lipids | 1 | 2003 | 269 | 0.050 |
Why?
|
| Blotting, Western | 1 | 2003 | 782 | 0.050 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2003 | 557 | 0.050 |
Why?
|
| Protein Binding | 1 | 2005 | 1457 | 0.050 |
Why?
|
| Genome-Wide Association Study | 1 | 2009 | 1621 | 0.050 |
Why?
|
| Binding Sites | 1 | 2003 | 1098 | 0.050 |
Why?
|
| Models, Molecular | 1 | 2003 | 1286 | 0.040 |
Why?
|
| Cell Line | 1 | 2003 | 2469 | 0.040 |
Why?
|
| Oxygen | 1 | 2003 | 726 | 0.040 |
Why?
|
| Proteins | 1 | 2003 | 777 | 0.040 |
Why?
|
| Antibodies, Monoclonal | 1 | 2003 | 1376 | 0.040 |
Why?
|
| Time Factors | 1 | 2003 | 5214 | 0.030 |
Why?
|
| Aged | 2 | 2008 | 18423 | 0.030 |
Why?
|
| Middle Aged | 2 | 2008 | 25040 | 0.030 |
Why?
|
| Adult | 1 | 2008 | 25659 | 0.020 |
Why?
|
| South Dakota | 1 | 2009 | 47 | 0.020 |
Why?
|
| Rosaniline Dyes | 1 | 2008 | 9 | 0.020 |
Why?
|
| Electrophoresis, Gel, Two-Dimensional | 1 | 2008 | 27 | 0.020 |
Why?
|
| Religion | 1 | 2009 | 87 | 0.020 |
Why?
|
| Male | 2 | 2008 | 40988 | 0.020 |
Why?
|
| Monocytes | 1 | 2009 | 216 | 0.020 |
Why?
|
| Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 2008 | 74 | 0.020 |
Why?
|
| Flow Cytometry | 1 | 2009 | 679 | 0.020 |
Why?
|
| Female | 2 | 2008 | 44550 | 0.020 |
Why?
|
| Myocytes, Smooth Muscle | 1 | 2008 | 135 | 0.020 |
Why?
|
| Linkage Disequilibrium | 1 | 2009 | 473 | 0.020 |
Why?
|
| Enhancer Elements, Genetic | 1 | 2009 | 267 | 0.020 |
Why?
|
| Chromosome Mapping | 1 | 2009 | 1074 | 0.020 |
Why?
|
| Oxidative Stress | 1 | 2008 | 448 | 0.020 |
Why?
|
| Software | 1 | 2008 | 654 | 0.020 |
Why?
|
| Decorin | 1 | 2003 | 5 | 0.020 |
Why?
|
| Guanidine | 1 | 2003 | 17 | 0.010 |
Why?
|
| Apolipoproteins | 1 | 2003 | 38 | 0.010 |
Why?
|
| Matrix Metalloproteinases | 1 | 2003 | 28 | 0.010 |
Why?
|
| Genotype | 1 | 2009 | 1852 | 0.010 |
Why?
|
| Extracellular Matrix Proteins | 1 | 2003 | 123 | 0.010 |
Why?
|
| Proteoglycans | 1 | 2003 | 121 | 0.010 |
Why?
|
| Endarterectomy, Carotid | 1 | 2003 | 73 | 0.010 |
Why?
|
| Interleukins | 1 | 2003 | 134 | 0.010 |
Why?
|
| Inflammation | 1 | 2008 | 923 | 0.010 |
Why?
|
| Peptide Fragments | 1 | 2003 | 460 | 0.010 |
Why?
|
| Models, Biological | 1 | 2008 | 1749 | 0.010 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2009 | 2357 | 0.010 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2009 | 2271 | 0.010 |
Why?
|
| Signal Transduction | 1 | 2008 | 3243 | 0.010 |
Why?
|
| Biomarkers | 1 | 2003 | 1718 | 0.010 |
Why?
|